Results 291 to 300 of about 1,116,885 (306)

Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea

Ca-A Cancer Journal for Clinicians, 2018
Clement Chung
exaly  

Evidence accumulates indicating periodontal disease as a risk factor for colorectal cancer or lymphoma

Ca-A Cancer Journal for Clinicians, 2017
exaly  

Primary tumor location found to impact prognosis and response to therapy in patients with metastatic colorectal cancer

Ca-A Cancer Journal for Clinicians, 2017
exaly  

Local consolidative therapy may be beneficial in patients with oligometastatic non‐small cell lung cancer

Ca-A Cancer Journal for Clinicians, 2017
exaly  

Cancer cachexia awareness, diagnosis, and treatment are lacking among oncology providers

Ca-A Cancer Journal for Clinicians, 2017
exaly  

Encouraging long‐term outcomes reported in patients with stage I non‐small cell lung cancer treated with stereotactic ablative radiotherapy

Ca-A Cancer Journal for Clinicians, 2017
exaly  

Immune checkpoint inhibitors are superior to docetaxel as second‐line therapy for patients with non‐small cell lung carcinoma

Ca-A Cancer Journal for Clinicians, 2018
exaly  

Disparities found in chemotherapy administration for human immunodeficiency virus‐associated lymphoma

Ca-A Cancer Journal for Clinicians, 2017
exaly  

Changes in inflammation and insulin pathways mediate the association between resistance training and breast cancer survival

Ca-A Cancer Journal for Clinicians, 2018
exaly  

Evidence supports the use of multidisciplinary team meetings

Ca-A Cancer Journal for Clinicians, 2017
exaly